Cancer Therapy-Associated Pulmonary Hypertension and Right Ventricular Dysfunction: Etiologies and Prognostic Implications

By sjmartinez • July 30, 2024

Leiva O, Beaty W, Soo S, Agarwal MA, Yang EH. Cancer Therapy-Associated Pulmonary Hypertension and Right Ventricular Dysfunction: Etiologies and Prognostic Implications. Rev Cardiovasc Med. 2024 Mar 5;25(3):87. doi: 10.31083/j.rcm2503087. PMID: 39076943; PMCID: PMC11263834.

Tags: cardio-oncology, Cardiology/Epi, cardiotoxicity, Publications, pulmonary hypertension, right ventricular dysfunction

Differences in Ambulatory Care Outcomes Between Trainees and Faculty: A Multi-center Study

Graham KL, Amat M, Norian E, Li J, Weintraub J, Shaik A, Boggan JC, Davy J, Lyons A, Semour L, Rogers R, Davis RB. Differences[...]

Comparative assessment of CAC and SIS plaque burden categories via AI-guided quantitative CT analysis

Iskander B, Ichikawa K, Punnanithinont N, Kambalapalli S, Kinninger A, Krishnan S, Lakshmanan S, Roy S, Budoff MJ. Comparative assessment of CAC and SIS plaque[...]

Association of Mechanical Circulatory Support and Cardiac Catheterization Laboratory Procedural Volumes with Outcomes of Cardiogenic Shock

Tabibian K, Vadlakonda A, Coaston T, Sakowitz S, Ebrahimian S, Srivastava PK, Benharash P. Association of Mechanical Circulatory Support and Cardiac Catheterization Laboratory Procedural Volumes[...]